US Stock MarketDetailed Quotes

GDRX GoodRx

Watchlist
  • 4.440
  • -0.050-1.11%
Close Dec 20 16:00 ET
  • 4.519
  • +0.079+1.78%
Post 20:01 ET
1.69BMarket Cap-111.00P/E (TTM)

GoodRx Key Stats

GoodRx Q3 2024 Earnings Date

Currency:USDNov 7, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
195.65M
195.25M
-403.81K
Miss Est.
+8.72%
+8.50%
-0.21%
EPS
0.02
0.01
-0.01
Miss Est.
+126.92%
+111.11%
-58.68%
Buy

Dec 21, 2024

GoodRx Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 202.982M--
--2024/Q4-- / 199.733M--
Nov 7, 20242024/Q3195.251M / 195.655M--
Aug 8, 20242024/Q2200.610M / 200.428M--
May 9, 20242024/Q1197.880M / 196.098M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 202.982M--
--2024/Q4-- / 199.733M--
Nov 7, 20242024/Q3195.251M / 195.655M--
Aug 8, 20242024/Q2200.610M / 200.428M--
May 9, 20242024/Q1197.880M / 196.098M--

Unlock Free Earnings Estimates

GoodRx Earnings Reports

Read more

Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Analysis

Analyst Rating

Updated: Dec 21, 2024

Buy

  • Buy

    46.67%
  • Hold

    46.67%
  • Sell

    6.67%

Price Target

No Data